glp-1 drugs medicare covers GLP-1s for $50/month starting July 2026 GLP-1 Weight-Loss Drug Demonstration Begins

Compounded medications are not covered

These GLP-1 receptor agonist medicines are injected once weekly

Phase 3 trial announcements will be made in 2026

The researchers noted that glucagon and GLP-1 can produce positive chronotropic and positive inotropic effects on the heart, but analyzed that the magnitude of the increase was similar to levels reported for existing GLP-1 receptor agonists

In a phase 2 clinical trial conducted on an obese population, over a 26-week period, patients who were administered a dose range of efinopegdutide from 5 mg to 10 mg experienced a weight reduction of up to 11.8%

Meier JJ, Kemmeries G, Holst JJ, Nauck MA